Results 151 to 160 of about 47,991 (257)

Rectal Neuroendocrine Tumor Presenting as Refractory Chronic Pruritus Ani: A Case Report. [PDF]

open access: yesCase Rep Gastroenterol
Tran TM   +6 more
europepmc   +1 more source

Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients. [PDF]

open access: yesNephrol Dial Transplant, 2023
Lengton R   +10 more
europepmc   +1 more source

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria

open access: yesAllergy, EarlyView.
ABSTRACT This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA2LEN) and its Urticaria and ...
T. Zuberbier   +221 more
wiley   +1 more source

Knowledge, Attitudes, and Practices of Dermatologists on Chronic Pruritus and Its Management. [PDF]

open access: yesCureus
Talwar A   +8 more
europepmc   +1 more source

Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab. [PDF]

open access: yesJAAD Case Rep, 2023
Wachuku CI   +5 more
europepmc   +1 more source

Chronic Arm Pruritus [PDF]

open access: yes, 2022
Anderson, Lorraine, Swain, Samantha
openaire  

Minimal Clinically Important Difference in Chronic Pruritus Appears to be Dependent on Baseline Itch Severity

open access: yesActa Dermato-Venereologica, 2019
Claudia Riepe   +5 more
doaj   +1 more source

Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema

open access: yesAllergy, EarlyView.
This study performed an unbiased molecular profiling of CHE patients across diverse etiologies to identify shared pathogenic drivers and evaluate the impact of IL‐4Rα blockade via dupilumab over 16 weeks. CHE shows a mixed immune signature involving type 1, 2, and 3 pathways with features of atopic dermatitis and psoriasis.
Perrine Gery   +25 more
wiley   +1 more source

Switching Long‐Term Prophylaxis to Donidalorsen for Hereditary Angioedema: 1‐Year OASISplus Results

open access: yesAllergy, EarlyView.
This study evaluated the long‐term safety and efficacy of donidalorsen in patients who switched from a long‐term prophylactic treatment (LTP) to donidalorsen with 1‐year outcomes. Patients who switched from LTP to donidalorsen experienced a 67.6% reduction in HAE attack rates over 52 weeks.
Marc A. Riedl   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy